Therapeutic Efficacy of Natural Phytochemicals as Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

Author:

Ahmad AdnanORCID,Pal KrishanORCID

Abstract

<p>Alzheimer’s Disease (AD) is a chronic degenerative brain illness marked by a slow, steady loss in cognitive function and behaviour. AD is an aging-related dementia that begins with memory loss and progresses to the destruction of brain functions as the neocortex suffers neuronal, synaptic, and dendritic connections. The formation of amyloid plaques causes the entire phenomenon to spread. Although there is presently no treatment, cholinesterase inhibitors give excellent temporary alleviation of symptoms in some individuals. The cholinergic hypothesis, which promotes cognition enhancement by regulating the production and release of acetylcholine in the brain, is now the basis for medication research and development. Acetylcholinesterase inhibitors and N-Methyl- D-Aspartate (NMDA) receptor antagonists are two drugs authorised to treat Alzheimer’s disease. Caregivers who do not have enough information on Alzheimer’s disease may feel that there is nothing they can do to manage the illness’s symptoms. This article aims to highlight the plant extract/compounds and FDA approved drugs which play the most significant role as acetylcholinesterase inhibitors in AD.</p>

Publisher

Informatics Publishing Limited

Subject

Public Health, Environmental and Occupational Health,Pollution,Ecology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3